Sail E0 Webinar
Question
Which pharma company seeks permission from DGCI for 'phase 2&3' clinical trials of Oxford vaccine under brand name "Covishield" in India?
Options:
A .  Indian Immunologicals
B .  Bharat Biotech
C .  Indian Drugs and Pharmaceuticals Limited
D .  Serum Institute of India
Answer: Option D

Submit Your Solution Below and Earn Points !
Next Question

Submit Solution

Your email address will not be published. Required fields are marked *

More Questions on This Topic :


Latest Videos

Latest Test Papers